PIASA Presenter
Profile of the Association
Pharmaceutical Trade organisation - voluntary membership
Members comprise research based multinational, local/ generic
and empowerment pharmaceutical companies operating in SA
18 members
Approximately 25 % Private Sector Market Share
Represents South Africa internationally as a member of the
International Federation of Pharmaceutical Manufacturers &
Associations (IFPMA)
Represent members’ interests in Africa as a member of NEPAD
Business Foundation
www.piasa.co.za
Pharmaceutical Associations
Self Medication
SMASA
17%
Local
Manufacturing
IMSA
Innovative
Medicines
32%
PHARMISA
15%
PIASA
25%
Innovative / Local
+ Generic
NAPM
11%
Generics
Our Mission
To sustain a favourable environment for the
continued development of the pharmaceutical
industry in South Africa as it strives to increase
access to quality medicines, with the ultimate
aim of saving lives and improving the quality of
life for all South Africans
PIASA’s Role
•
Represent members and industry in dealing with government, business and
professional organisations
•
Promote and safeguard members interests in South Africa by striving to
influence policy developments affecting the health sector
•
Analyse and interpret trends (national & international) and the impact of
changes to legislation on the industry
•
Keep abreast of African and international policy through our representation
as a member of the NEPAD Business Foundation and the International
Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
•
Keep members abreast of legal, labour, scientific, technical, economic and
trade issues
•
Provide relevant information and advice as appropriate
What are the Goals of PIASA?
• To promote the environment for the provision
of quality medicines to all South Africans
• To sustain a favourable environment for the
pharmaceutical industry locally
• To partner with government and the private
sector
• To be a unifying force in helping find South
African solutions to South Africa’s challenges in
healthcare
PIASA’s Role
• Respect for intellectual property rights
• Commitment to good corporate governance
• Commitment to the Code of Marketing
Practice
• Adherence to best practice in manufacturing,
clinical research, distribution and regulatory
issues
The PIASA Structure
•
Executive Council (elected 8 Multinational and 4 Local/Generic/
Black Empowered) – Strategic Direction & Leadership
Management Council – Financial & Administration
•
Identified Strategic Priority Areas
•
Management Council
Pierre Bosch
Jonathan Louw
Steve Speller
Laura Engelbrecht Joubert
Science & Technology Committee
(SciTech)
Kobus Venter
Executive Council
President
Pierre Bosch
Marketing Committee
Steve Speller
Government Affairs,
Policy and IP
Steve Speller
Transformation
Health Outcomes
Communication
Amanda Wilde
Laura Engelbrecht Joubert
Richard de Chastelain
Skills Group
Vicki St Quintin
Supported by the Secretariat
Strategic Priority Areas
Science & Technology
Committee (SciTech)
scientific, clinical and technical
Executive Council
PIASA’s decision making body,
sets strategy & determines
policy
matters
Marketing Committee
Government Affairs, Policy and IP
• Ensure good relationship with
Government;
• Continued liaison with DoH and DTI;
• Constructive input legislative issues;
and
• Discussions on trading conditions
• Strives to maintain a sound IP
environment to encourage investment
Transformation
Focus on Black
Economic
Empowerment
•
•
•
Communication
Image of industry and
PIASA
Communication with
members & their staff
Communication to
professional bodies, trade
associations and others
Health Outcomes
Address issues affecting
funding of medicines in the
private sector with a focus
on the interest of patients
Standing Committees
Executive Council
SciTech
(Science & Technology Committee)

Acts in members’ interest on
scientific, clinical and technical
matters

Analyses and interprets the effect of
national & international changes
in regulatory, scientific and technical
matters impacting on the local
pharmaceutical industry

Deals with Good Manufacturing
Practice & Good Clinical Practice
Marketing Committee
 Compliance with ethical
marketing practices
 Self-regulation on Code
complaints
SciTech Sub Groups:
Clinical – Market SA’s clinical research capability
Regulatory - Leadership in ITG
• Drive awareness & influence key stakeholders to
improve operational efficiency of MCC
• Active participation in harmonisation initiatives
• Influencing technical guideline updates
Pharmacovigilance & Medical Info
• Share best practice
• Support companies audit readiness
• Improve quality of Medical Information services
• Influencing technical guideline updates
Quality Management – Share best practice
• Risk management audit & readiness
• Chair industry Cold Chain Forum
Members of PIASA
Abbott Laboratories South Africa (Pty) Ltd
GlaxoSmithKline South Africa
Acro (Pty) Ltd
GlaxoSmithKline Southern Africa
Adcock Ingram Healthcare (Pty) Ltd
iNova Pharmaceuticals (Pty) Ltd
Alcon Laboratories (Pty) Ltd
Janssen
Allergan Pharmaceuticals (Pty) Ltd
Key Oncologics (Pty) Ltd
AstraZeneca Pharmaceuticals (Pty) Ltd
Nkunzi Pharmaceuticals (Pty) Ltd
Bayer HealthCare
Novo Nordisk (Pty) Ltd
Covidien (Pty) Ltd
Servier Laboratories SA Pty) Ltd
Galderma Laboratories (Pty) Ltd
Umsinsi Health Care Pty Ltd
Secretariat Structure
Chief Operating Officer
Vicki St Quintin
Reports to Management Council
Financial Function
Contracted out
Head: Scientific and
Regulatory Affairs
Kirti Narsai
Personal Assistant & Office
Administrator
Betsie Von Wielligh
Office Assistant
Agreta Njeje
Scientific and Regulatory Affairs
Coordinator
Christine Schoeman
Pharmaceutical Industry
The pharmaceutical industry in SA is represented by a number of trade Associations i.e.:
• Pharmaceutical Industry Association of SA (PIASA) – represents 18 research based
multinational, local generic and local empowerment pharmaceutical companies
• represents South Africa internationally as a member of the International Federation
of Pharmaceutical Manufacturers & Associations (IFPMA)
• represent members’ interests in Africa as a member of NEPAD Business Foundation
• Innovative Medicines SA (IMSA) - represents research based pharmaceutical
companies
• National Association of Pharmaceutical Manufacturers (NAPM) - represents the majority
of generic medicine companies operating in South Africa
• Self Medication Association of SA (SMASA) – represents the interests of companies
involved in the marketing of self-medication products
• Pharmaceuticals Manufactured in South Africa (PHARMISA) – represents generic
medicine in South Africa
Bringing Hope & Health to All South Africans
•
Global MNC’s
• Local / Generic Cos